# SUPN: Supernus Pharmaceuticals, Inc.

- Industry: Pharmaceutical Preparations
- Current price: $42
- Price updated: Sep 19, 2026
- Total congressional trades: 3
- Politicians trading: 1
- Last traded: Dec 11, 2025
- Source: https://tryglasshouse.ai/companies/SUPN.md

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

# Congressional trading history

- Page: 1 of 1
- Results: 3 of 3
- Pagination query parameter: `page`

## 1. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Buy, $1,001 - $15,000
- Dates: traded Dec 11, 2025, disclosed Jan 12, 2026
- Market context: $46.51 at trade, $42 current (-9.70%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/aa2edc15-972d-4c10-9859-5edaebb58ac8.md

## 2. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Oct 9, 2025, disclosed Nov 18, 2025
- Market context: $49.51 at trade, $42 current (-15.17%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/b16647a6-4e5b-4f90-8b0b-56189f1485b5.md

## 3. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Buy, $1,001 - $15,000
- Dates: traded Mar 24, 2025, disclosed Apr 7, 2025
- Market context: $32.7 at trade, $42 current (+28.44%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/41d6a912-9493-497e-99af-c67c328b54e2.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.